Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/22/2003EP1353946A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
10/22/2003EP1353927A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
10/22/2003EP1353926A1 Mikanolide derivatives, their preparation and therapeutic uses
10/22/2003EP1353922A1 Cyclin dependent kinase inhibiting purine derivatives
10/22/2003EP1353921A1 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
10/22/2003EP1353919A2 Novel quinuclidine derivatives and medicinal compositions containing the same
10/22/2003EP1353918A1 Morpholine derivatives as antagonists of orexin receptors
10/22/2003EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353910A2 Lactam compound
10/22/2003EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353906A1 Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/22/2003EP1353904A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2003EP1353903A2 Thiol-based naaladase inhibitors
10/22/2003EP1353902A2 Inhibitors of serine protease activity of matriptase or mtsp1
10/22/2003EP1353727A2 Combinations of an angiotensin receptor antagonist and an anti-hypertensive drugor a statin, for the treatment of sexual dysfunction
10/22/2003EP1353695A2 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
10/22/2003EP1353694A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/22/2003EP1353693A2 Pharmaceutical combination containing a 4-quinazolineamine and another anti-neoplastic agent for the treatment of cancer
10/22/2003EP1353692A2 Methods and compositions for treatment of ocular neovascularization and neural injury
10/22/2003EP1353687A2 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
10/22/2003EP1353683A2 Ghrelin analogs
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1353661A2 Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
10/22/2003EP1353658A1 Regulation of organic nitrate tolerance
10/22/2003EP1353624A2 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
10/22/2003EP1255538B1 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for the manufacture of a medicament for treating and/or preventing cancers
10/22/2003EP1196135B1 Compositions comprising organosiloxane resins for delivering oral care substances
10/22/2003EP1194441B1 A2a receptor agonists
10/22/2003EP1192122B1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
10/22/2003EP1178966B1 Quinoline derivatives as inhibitors of mek enzymes
10/22/2003EP1150961B1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
10/22/2003EP1144386B1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
10/22/2003EP1140105B1 Controlled release galantamine composition
10/22/2003EP1089993B1 5-ht1f agonists
10/22/2003EP1084122B1 Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity
10/22/2003EP1056754B1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
10/22/2003EP1056744B1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines
10/22/2003EP1056460B1 Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system
10/22/2003EP1047665B1 Matrix metalloprotease inhibitors
10/22/2003EP0986572B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
10/22/2003EP0980368B1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
10/22/2003EP0927184B1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use
10/22/2003EP0896522B1 Methods of regulating skin appearance with vitamin b 3 compound
10/22/2003EP0815221B1 A novel growth factor and a genetic sequence encoding same
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003EP0658209B1 Endothelial lineage specific transcriptional regulatory element from tek
10/22/2003EP0651654B1 Use of lysozyme dimer for the manufacture of a medicament for modulating natural defensive mechanisms
10/22/2003CN1451017A Selective cyclic peptides
10/22/2003CN1451016A Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1451010A Benzosulfones with calcium antagonist activity
10/22/2003CN1451009A Glucocortiocoid-selective antinflammatory agents
10/22/2003CN1451007A Adenosine A2A receptor antagonists
10/22/2003CN1451006A I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives
10/22/2003CN1451005A 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation
10/22/2003CN1451002A Indole derivatives for treating central nervous system disease
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450998A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450997A Inhibitors of copper-containing amine oxidases
10/22/2003CN1450996A 2-guanidino-4-aryl-quinazoline
10/22/2003CN1450995A 5-hydroxy indazole derivatives for treating glaucoma
10/22/2003CN1450991A Hydroxamate derives useful as deacetylase inhibitors
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1450923A Method and compositions for administering taxanes orally to human patients
10/22/2003CN1450912A CD40 antagonists for use in treating psoriasis and other inflammatory skin conditions
10/22/2003CN1450905A Method for improving the cell protection
10/22/2003CN1450898A Compounds for treating fibromyalgia and chronic fatigue syndrome
10/22/2003CN1450893A Method for treatment of sepsis
10/22/2003CN1449818A Decoction for anti-SARS
10/22/2003CN1449800A Traditional Chinese medicine for treating wind-cold type of common cold and preparation process thereof
10/22/2003CN1449792A Medicine composition with synergrstic action and preparation process and use thereof
10/22/2003CN1449750A Gabapentin slow -released composition
10/22/2003CN1449741A 栓塞材料 Embolic material
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/22/2003CN1125040C Therapeutic compound-fatty acid conjugates
10/22/2003CN1124849C Nail health disinfecting liquid
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635764 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635669 Kinase inhibitor; benign prostatic hyperplasia
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635658 Amino-tetralin derivatives as muscarinic receptor antagonists
10/21/2003US6635651 Inhibitors of thrombin induced platelet aggregation
10/21/2003US6635650 Such as N-(2-(7-(2-((8-(2-(acetyl-amino)ethyl)-2-naphthyl) oxy)ethoxy)-1-napthyl)ethyl)acetamide for treating or preventing melatoninergic disorders
10/21/2003US6635645 2,5,-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
10/21/2003US6635644 Pyrimido(1,6-b)pyridazine derivatives used as p38 inhibitors a mammalian protein kinase is involved in cell proliferation, cell death and response to extracellular stimuli
10/21/2003US6635643 For treating conditions which are related to impairment of gastric emptying
10/21/2003US6635642 Poly(ADP-ribose) polymerase inhibitors; tissue damage treatment
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635640 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
10/21/2003US6635639 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
10/21/2003US6635638 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/21/2003US6635637 Cyclic oxyguanidine protease inhibitors
10/21/2003US6635635 Benzothiadiazine compounds
10/21/2003US6635629 For therapy and prophylaxis of inflammation, asthma, an allergic disease, chronic obstructive pulmonary disease, atopic dermatitis, solid tumors, AIDS, ischemia, and cardiac arrhythmias
10/21/2003US6635483 Antisense polynucleotide targeted to a nucleic acid encoding the gene, thereby suppressing its expression; cDNA encapsulated in liposome; use as antitumor, anticarcinogenic or antiapoptotic; Alzheimer's disease
1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 1564